The global digital biomanufacturing market is estimated to grow from USD 2 billion in the current year to USD 12.3 billion by 2035, at a CAGR of 17.9% during the forecast period, till 2035.
The market sizing and opportunity analysis has been segmented across the following parameters:
Type of Technology
- Process Analytical Technology (PAT)
- Data Analysis Software (DAS)
- Manufacturing Execution Systems (MES)
- Digital Twins
Deployment Options
- Cloud-based
- On-premises
Type(s) of Biologic(s) Manufactured
- Antibodies
- Cell and Gene Therapies
- Proteins
- Vaccines
- Others
Key Geographical Regions
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and North Africa
Digital Biomanufacturing Market: Growth and Trends
Digital biomanufacturing employs various digital software and platforms, such as process analytical technology (PAT), data analysis software (DAS), manufacturing execution system (MES) and digital twin, to facilitate improvement in the overall biomanufacturing process. It has been demonstrated that the use of digital biomanufacturing approaches can boost the productivity of procedures and the longevity of existing infrastructure. The modernization of the biomanufacturing process has been more visible and successful due to advancements in data analytics and data science. Innovative technologies, such as AI and digital twins, have become an integral part of biopharmaceutical companies’ strategy to future-proof their business operations and address various issues, including growing expenses, stringent regulatory guidelines and deteriorating profit margins.
Considering the current market trends and innovation, it is anticipated that the next generation of machine learning technologies will be integrated with advanced data analytics, and process and equipment modeling to form comprehensive systems, for the purpose of real-time monitoring and predictive analysis. Driven by the increasing number of biologics approved, consequent growth in the number of biologics-focused clinical trials, rise in R&D activity and rising popularity of cloud and IoT based process technologies, the digital biomanufacturing industry is expected to witness steady growth over the coming years.
Digital Biomanufacturing Market: Key Insights
The report delves into the current state of the digital biomanufacturing market and identifies potential growth opportunities within the industry.
Some key findings from the report include:
- Currently, over 100 firms claim to offer a variety of novel digital biomanufacturing solutions in order to cater to the rising demand for biopharmaceuticals.
- 140+ platforms, based on PAT, DAS, MES, digital twins and other such technologies, are being offered for digitalization of the biologic production process.
- Over 85% of the process analytical technologies are capable of offering process automation and bioprocess optimization and controls, majority of these platforms support the manufacturing of proteins and antibodies.
- Data analysis software offers a wide spectrum of technical competencies, including process intelligence and data integration; predominantly, these platforms are compatible with artificial intelligence-based programs.
- Leveraging their expertise, ~80% of players are offering cloud-based MES solutions that can be integrated with numerous types of software to carry out production tracking, performance analysis and data integration functions.
- The developer landscape is dominated by the presence of established players; asset / process management emerged as the prominent application areas for digital twin technologies.
- In pursuit of gaining a competitive edge, digital biomanufacturing providers are upgrading their existing software capabilities and enhancing their biologic focused technology portfolios.
- The growing preference for digitalization of bioprocessing is evident from the rise in partnership activity; it is worth highlighting that more than 80% of the deals were forged in the last three years.
- The adoption of digital biomanufacturing solutions has increased considerably in recent years; white spaces in this domain present significant growth opportunities for innovators.
- Fundamental advancements in the field of smart biomanufacturing will promote process robustness and product quality; this will inevitably culminate in accelerated growth of the market.
- Driven by continuous technological innovations, this domain is anticipated to witness steady growth; technologies focused on digital twins are expected to gain significant traction with an annualized growth of 19%.
Digital Biomanufacturing Market: Key Segments
Digital Twins is the Fastest Growing Segment of the Digital Biomanufacturing Market
Based on the type of technology, the market is segmented into process analytical technology, data analysis software, manufacturing execution system and digital twin. At present, the process analytical technology segment holds the maximum share of the digital biomanufacturing market. It is worth highlighting that the digital biomanufacturing market for digital twins is likely to grow at a relatively higher CAGR.
Currently, the On-premises Segment Occupies the Largest Share of the Digital Biomanufacturing Market
Based on the deployment options, the market is segmented into cloud-based and on-premises. Currently, the on-premises segment holds the maximum share of the digital biomanufacturing market. It is worth highlighting that the digital biomanufacturing market for cloud-based deployment option is likely to grow at a relatively higher CAGR.
Cell Therapies and Gene Therapies are the Fastest Growing Segment of the Digital Biomanufacturing Market During the Forecast Period
Based on the type of biologic(s) manufactured, the market is segmented into antibodies, cell therapies and gene therapies, proteins, vaccines, and others. At present, the antibody segment holds the maximum share of the digital biomanufacturing market. It is worth highlighting that the digital biomanufacturing market for cell therapies and gene therapies is likely to grow at a relatively higher CAGR.
North America Accounts for the Largest Share of the Market
Based on key geographical regions, the market is segmented into North America, Europe, Asia-Pacific, Latin America, and Middle East and North Africa. The majority share is expected to be captured by players based in North America. It is worth highlighting that, over the years, the market in Europe is expected to grow at a higher CAGR.
Key Players in the Digital Biomanufacturing Market Include:
- AspenTech
- Dassault Systèmes
- FUJIFILM Diosynth Biotechnologies
- GE Healthcare
- Körber
- Merck
- Sartorius
- Thermo Fisher Scientific
Primary Research Overview
The opinions and insights presented in this study were influenced by discussions conducted with multiple stakeholders. The research report features detailed transcripts of interviews held with the following industry stakeholders:
- Chief Executive Officer and President, BioIntelligence Technologies
- Managing Director and Chief Executive Officer, Yokogawa Insilico Biotechnology
- Vice President of Operations and Strategic Initiatives, Aizon
- Director, Business Development and Channel Sales, and Quality and Manufacturing Digitization Specialist, MasterControl
- Director of Sales, Trunovate
- Business Consultant, Dassault Systèmes
Digital Biomanufacturing Market: Research Coverage
- Market Sizing and Opportunity Analysis: The report features an in-depth analysis of the digital biomanufacturing market, focusing on key market segments, including type of technology, deployment options, types of biologics manufactured and key geographical regions.
- Market Landscape: A comprehensive evaluation of digital biomanufacturing companies (offering digital biomanufacturing technologies - Process Analytical Technology, Data Analysis Software, Manufacturing Execution System and Digital Twin), considering various parameters, such as year of establishment, company size (in terms of number of employees), location of headquarters, type of company, number of platforms offered, deployment options, platform capabilities, software capabilities, type(s) of biologic(s) manufactured, other compatible platforms, type of end user(s), integrating software, manufacturing operation management (MOM), product lifecycle management (PLM), human resource management (HRM)), type of service(s) offered and area(s) of application.
- Technology Competitiveness Analysis: A comprehensive competitive analysis of digital biomanufacturing technologies, examining factors, such as supplier strength, technology portfolio and type(s) of biologic(s) manufactured.
- Company Profiles: In-depth profiles of key industry players offering digital biomanufacturing technologies, focusing on company overviews, capabilities of digital technologies offered by these firms, recent developments and an informed future outlook.
- Competitive Benchmarking Analysis: A competitive benchmarking analysis highlighting the existing capabilities companies, across key peer groups.
- Partnerships and Collaborations: An analysis of partnerships established in this sector, since 2018, based on multiple relevant parameters, such as year of partnership, type of partnership, type of technology, most active players (in terms of number of deals inked) and regional distribution of partnership activity.
- Market Concentration Analysis: A detailed analysis highlighting the market concentration of key industry stakeholders across various regions, based on prevalent parameters, such as years of entrance, company size, type of technology, number of platforms offered and number of partnerships inked.
- Industry Lifecycle Analysis: A comprehensive analysis of the digital biomanufacturing industry that outlines its various stages, such as emergence, growth, maturation and decline. This analysis aims to enhance understanding of the current phase of the industry on the lifecycle chart based on historical trends, partnership dynamics, and investments made by stakeholders in this field. Additionally, it highlights the impact of key factors that are likely to drive the growth of the market. The report also discusses both short-term and long-term effects of key factors anticipated to significantly influence the broader adoption of digitalization in the field of biomanufacturing.
Key Questions Answered in this Report
- How many companies are currently engaged in this market?
- Which are the leading companies in this market?
- What kind of partnership models are commonly adopted by industry stakeholders?
- What factors are likely to influence the evolution of this market?
- What is the current and future market size?
- What is the CAGR of this market?
- How is the current and future market opportunity likely to be distributed across key market segments?
Reasons to Buy this Report
- The report provides a comprehensive market analysis, offering detailed revenue projections of the overall market and its specific sub-segments. This information is valuable to both established market leaders and emerging entrants.
- Stakeholders can leverage the report to gain a deeper understanding of the competitive dynamics within the market. By analyzing the competitive landscape, businesses can make informed decisions to optimize their market positioning and develop effective go-to-market strategies.
- The report offers stakeholders a comprehensive overview of the market, including key drivers, barriers, opportunities, and challenges. This information empowers stakeholders to stay abreast of market trends and make data-driven decisions to capitalize on growth prospects.
Additional Benefits
- Complimentary PPT Insights Packs
- Complimentary Excel Data Packs for all Analytical Modules in the Report
- 10% Free Content Customization
- Detailed Report Walkthrough Session with Research Team
- Free Updated report if the report is 6-12 months old or older
Table of Contents
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AspenTech
- Dassault Systèmes
- FUJIFILM Diosynth Biotechnologies
- GE Healthcare
- Körber
- Merck
- Sartorius
- Thermo Fisher Scientific
Methodology
LOADING...
